Skip to content

Clinical trials

Carcinoma, Hepatocellular trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Country / region: Denmark Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20102
20131
20161
20171
20192
20203
20222
20234
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting5
Terminated4
Active, not recruiting3
Not yet recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Aarhus6
Rigshospitalet, Denmark4
Merck Sharp & Dohme LLC2
AbbVie1
Abbott1
Bayer1
BioInvent International AB1
Eisai Inc.1
GlaxoSmithKline1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular22
Neoplasms3
Cholangiocarcinoma2
Colorectal Neoplasms2
Liver Neoplasms2
Neoplasm Metastasis2
Adenocarcinoma1
Adrenocortical Carcinoma1
Bile Duct Neoplasms1
Biliary Tract Neoplasms1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.